Document text
Principal Investigator: Elke BergmannLeitner
Organization: THOMAS JEFFERSON UNIVERSITY
Fiscal Year: 2022
Award: $225,781
Funding agency: Eunice Kennedy Shriver National Institute of Child Health and Human Development
PROJECT SUMMARY
As COVID-19 pandemic continues with the evolution of new strains, we acknowledge the groundwork that has
been done evaluating maternal immunity following COVID-19 vaccine or disease exposure in pregnancy, and
passive transmission of antibodies in cord blood and breastmilk. There remains a significant knowledge gap at
this time relating to first, the impact of booster vaccination on maternal immunity in pregnancy and lactation
taking into consideration new strains, and second an understanding of the strength and durability of passively
acquired infant immunity through evaluation of infant serology following maternal vaccination in pregnancy or
breastfeeding. This knowledge gap has become even more significant in light of the recently started widespread
administration of COVID vaccines and now booster doses to pregnant and breastfeeding women and new
virulent strains. The impact of COVID-19 vaccination on the maternal-fetal unit needs to be assessed by profiling
maternal serologic and immunologic response to vaccination during pregnancy and post partum, and expanding
on assessment of breastmilk and cordblood with infant serological studies as well. We propose a multi arm cohort
study to carry out a comprehensive evaluation of the impact of COVID-19 booster dose, initial vaccine, and
COVID-19 disease on the maternal fetal unit and post-natal infant immunity. This immunoprofiling effort will
provide a valuable characterization of humorally mediated immunity in both mother and infant that that can guide
clinical vaccine trials and protocols in pregnancy, identify potential neonatal benefits from passive immunity, and
inform timing of infant vaccination. The COVID-19 pandemic has prompted the rapid initiation of immunoprofiling
studies, but ours is unique: 1) Unlike studies to date we will evaluate longitudinal infant immunity to examine the
functional immunity gained from maternal vaccine exposures 2) We are building on an existing cohort of pregnant
and lactating women exposed to COVID-19 disease and an initial mRNA vaccine course, as well as banked
control samples, to allow for multiple comparison in evaluating immune correlates of vaccine/booster in
pregnancy or lactation 3) by using highly dose-sparing, multiplex electroluminescence-based assays, it will
characterize a wide range of antibody characteristics of SARS-CoV2 infection and vaccination to characterize
the change in serological and functional SARS CoV2 immune profile in mother and neonate following COVID-
19 vaccine and booster exposure 4) by assessing paired maternal, cordblood, breastmilk, and infant blood we
will study the role of timing of exposure and maternal on long term neonatal and infant functional immunity; 5)
we will use machine-learning to identify predictive correlates of SARS-CoV2 immunity that could help guide
vaccine research to maximize maternal and neonatal immunity.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV S protein><2019-nCoV spike glycoprotein><2019-nCoV spike protein><2019-nCoV vaccine><Ab-mediated immunity><Ab-mediated protection><Antibodies><Antibody Response><Antibody immunity><Antibody protection><Antibody-mediated protection><Assay><Bioassay><Biologic Assays><Biological><Biological Assay><Blood><Blood Reticuloendothelial System><Blood Serum><Booster Immunization><Breast Feeding><Breast Milk><Breast fed><Breastfed><Breastfeeding><Breastmilk><COVID><COVID crisis><COVID epidemic><COVID pandemic><COVID-19><COVID-19 S protein><COVID-19 affected><COVID-19 antibody><COVID-19 booster><COVID-19 consequence><COVID-19 crisis><COVID-19 effect><COVID-19 epidemic><COVID-19 exposure><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 immunity><COVID-19 impact><COVID-19 impacted><COVID-19 infection><COVID-19 pandemic><COVID-19 public health crisis><COVID-19 spike glycoprotein><COVID-19 spike protein><COVID-19 vaccination><COVID-19 vaccine><COVID-19 vaccine booster><COVID-19 virus><COVID19><COVID19 S protein><COVID19 crisis><COVID19 epidemic><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 immunity><COVID19 infection><COVID19 pandemic><COVID19 public health crisis><COVID19 spike glycoprotein><COVID19 spike protein><COVID19 vaccination><COVID19 vaccine><COVID19 virus><CV-19><CV19><Characteristics><Chronologic Fetal Maturity><City Hospitals><Clinical Research><Clinical Study><CoV disease><CoV-2><CoV2><Cohort Studies><Communicable Diseases><Concurrent Studies><Cord Blood><Coronaviridae><Coronavirus><Data><Data Analyses><Data Analysis><Data Analytics><Discipline of obstetrics><Disease><Disorder><Dose><Early-Stage Clinical Trials><Evaluation><Evolution><Fetal Age><Frequencies><Future><Gestation><Gestational Age><Guidelines><Health><Hospitals><Human Milk><Human Mother's Milk><Immune><Immune response><Immunes><Immunity><Immunological response><Immunology><Impact evaluation><Infant><Infection><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Knowledge><Lactation><Life><Light><Machine Learning><Mammary Gland Milk><Maternal Immunity><Maternal antibody><Maternal-fetal medicine><Maternally-Acquired Immunity><Measures><Mediating><Methods><Metropolitan Hospitals><Mother's Milk><Mothers><Neonatal><Neonatology><Nucleoproteins><Obstetrics><Outcome><Passive Immunity><Patients><Phase 1 Clinical Trials><Phase I Clinical Trials><Photoradiation><Physiology><Populations at Risk><Postpartum><Postpartum Period><Pregnancy><RNA vaccine><RNA-based vaccine><Research><Role><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 S protein><SARS-CoV-2 antibody><SARS-CoV-2 booster><SARS-CoV-2 epidemic><SARS-CoV-2 exposure><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 immunity><SARS-CoV-2 infection><SARS-CoV-2 pandemic><SARS-CoV-2 spike glycoprotein><SARS-CoV-2 spike protein><SARS-CoV-2 vaccination><SARS-CoV-2 vaccine><SARS-CoV-2 vaccine booster><SARS-CoV2><SARS-CoV2 S protein><SARS-CoV2 antibody><SARS-CoV2 epidemic><SARS-CoV2 exposure><SARS-CoV2 infection><SARS-CoV2 pandemic><SARS-CoV2 spike glycoprotein><SARS-CoV2 spike protein><SARS-CoV2 vaccine><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-coronavirus-2 vaccine><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Secondary Immunization><Serology><Seroprevalences><Serum><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 S protein><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 exposure><Severe acute respiratory syndrome coronavirus 2 immunity><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 spike glycoprotein><Severe acute respiratory syndrome coronavirus 2 spike protein><Severe acute respiratory syndrome coronavirus 2 vaccination><Severe acute respiratory syndrome coronavirus 2 vaccine><Severe acute respiratory syndrome related corona virus 2><Specialist><Specificity><Time><Transmission><Treatment Efficacy><Umbilical Cord Blood><Urban Hospitals><Vaccination><Vaccine Clinical Trial><Vaccine Research><Vaccines><Vertical Disease Transmission><Vertical Transmission><Virulent><Woman><Wuhan coronavirus><acquired immunity><antibody against COVID-19><antibody against SARS-CoV-2><antibody against SARS-CoV2><antibody against coronavirus disease 2019><antibody against severe acute respiratory syndrome coronavirus 2><antibody to COVID-19><antibody to SARS-CoV-2><antibody to SARS-CoV2><antibody to coronavirus disease 2019><antibody to severe acute respiratory syndrome coronavirus 2><antibody-mediated immunity><arm><base><biologic><biomarker identification><booster against COVID-19><booster against SARS-CoV-2><booster dose><booster shot><booster vaccination><booster vaccine><cohort><corona virus><corona virus disease><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><corona virus disease 2019 vaccine><coronavirus disease><coronavirus disease 2019><coronavirus disease 2019 S protein><coronavirus disease 2019 antibody><coronavirus disease 2019 consequence><coronavirus disease 2019 crisis><coronavirus disease 2019 effect><coronavirus disease 2019 epidemic><coronavirus disease 2019 exposure><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 immunity><coronavirus disease 2019 impact><coronavirus disease 2019 infection><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 spike glycoprotein><coronavirus disease 2019 spike protein><coronavirus disease 2019 vaccination><coronavirus disease 2019 vaccine><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 impact><coronavirus disease-19 pandemic><coronavirus disease-19 vaccine><coronavirus disease-19 virus><coronavirus infectious disease-19><cross reactivity><data interpretation><evaluate vaccines><experience><exposure to COVID-19><exposure to SARS-CoV-2><exposure to SARS-CoV2><exposure to Severe acute respiratory syndrome coronavirus 2><exposure to coronavirus disease 2019><fetal><fetal cord blood><hCoV19><high dimensionality><host response><immune system response><immunity against COVID-19><immunity against COVID19><immunity against SARS-CoV-2><immunity against Severe acute respiratory syndrome coronavirus 2><immunity against coronavirus disease 2019><immunity to COVID-19><immunity to COVID19><immunity to SARS-CoV-2><immunity to Severe acute respiratory syndrome coronavirus 2><immunity to coronavirus disease 2019><immunoresponse><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><interest><intervention efficacy><lactating><lactational><mRNA vaccine><mRNA-based vaccine><machine learned><marker identification><maternal immunization><maternal milk><maternal serum><maternal vaccination><mother to child transmission><nCoV2><neonatal immunity><neonate><novel><phase I protocol><post-partum><potential biological marker><potential biomarker><pregnant><response><severe acute respiratory syndrome coronavirus 2 antibody><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><social role><therapeutic efficacy><therapy efficacy><translational study><transmission process><vaccinate against COVID-19><vaccinate against COVID19><vaccinate against SARS-CoV-2><vaccinate against coronavirus disease 2019><vaccinate against severe acute respiratory syndrome coronavirus 2><vaccination against COVID-19><vaccination against COVID19><vaccination against SARS-CoV-2><vaccination against Severe acute respiratory syndrome coronavirus 2><vaccination against coronavirus disease 2019><vaccination protocol><vaccination study><vaccination trial><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine evaluation><vaccine for novel coronavirus><vaccine protocol><vaccine response><vaccine responsiveness><vaccine screening><vaccine study><vaccine testing><vaccine trial><vaccine-induced response><work group><working group>